Fred Alger Management’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-11,537
Closed -$2.64M 469
2024
Q4
$2.64M Buy
11,537
+5,878
+104% +$1.42M 0.01% 309
2024
Q3
$1.38M Buy
+5,659
New +$1.26M 0.01% 343
2020
Q4
Sell
-193
Closed -$33K 500
2020
Q3
$33K Sell
193
-29,410
-99% -$5.43M ﹤0.01% 421
2020
Q2
$5.68M Buy
29,603
+13,722
+86% +$2.25M 0.02% 220
2020
Q1
$2.34M Buy
+15,881
New +$2.53M 0.01% 261
2019
Q2
Sell
-118
Closed -$12K 551
2019
Q1
$12K Hold
118
﹤0.01% 479
2018
Q4
$13K Buy
+118
New +$12.6K ﹤0.01% 470

Other funds holding RMD

Fred Alger Management's RMD Position: Q1 2025 in Review

Fred Alger Management sold out of ResMed (RMD) in Q1 2025, closing a stake of 11,537 shares — an estimated $2.64M sold.

Fred Alger Management first reported a position in RMD in Q4 2018 and held it in 7 quarters. The position peaked at $5.68M in Q2 2020. 885 funds tracked by Wall St. Rank hold RMD as of Q1 2025.

  • Fred Alger Management reported no remaining ResMed position as of Q1 2025 after selling out during the quarter.
  • Fred Alger Management sold 11,537 ResMed shares in Q1 2025, an estimated $2.64M.
  • Fred Alger Management first reported a position in ResMed in Q4 2018 and held it in 7 quarters.
  • Fred Alger Management's ResMed position peaked at $5.68M in Q2 2020.
  • 885 funds tracked by Wall St. Rank held ResMed as of Q1 2025.

Based on Fred Alger Management's 13F filing for Q1 2025, filed 16 May 2025.